Design of Effisayil™ 2: A Randomized, Double-Blind, Placebo-Controlled Study of Spesolimab in Preventing Flares in Patients with Generalized Pustular Psoriasis.

Akimichi MoritaSiew Eng ChoonHervé BachelezMilan J AnadkatSlaheddine MarrakchiMin ZhengTsen-Fang TsaiHamida TurkiHarry HuaSushmita RajeswariChristian ThomaA David Burden

Published in: Dermatology and therapy (2022)

NCT04399837.

Keyphrases

double blind
placebo controlled
clinical trial
phase iii
phase ii
atopic dermatitis
randomized controlled trial